Skip to main content
. Author manuscript; available in PMC: 2014 Feb 12.
Published in final edited form as: Circulation. 2013 Jan 11;127(6):691–702. doi: 10.1161/CIRCULATIONAHA.112.128132

Table 3.

Description of 34 VAD-related infections

Event
#
Causative
Organism(s)
Description of
VAD Infection*
Device
Type
Days on VAD
support prior
to infection
Gram-Positive
1 Staphylococcus
epidermidis
DL, PP, BSI HM I 36
2 Coagulase-negative
staphylococcus
DL, BSI, PP HM I 8
3 DL +/− BSI HM I 14
4 DL, PP, BSI HM I 22
5 DL, PP, BSI,
septic emobli
HM II 15
6 PP HM II 20
7 DL HM II 102
8 Staphylococcus
aureus
DL HM I 195
9 DL, BSI, mycotic
aneurysm with
septic emboli and
involvement of
inflow/outflow tract
HM I 310
10 DL HM II 34
11 DL HM II 285
12 DL, PP, BSI HM II 177
13 DL HM II 120
14 DL, BSI HM II 42
15 Enterococcus
faecalis
DL, PP, BSI HM I 68
16 DL, SW, PP, BSI HM I 44
17 E. faecalis and/or
CoNS
PP, BSI +/− DL HM I 28
18 E. faecium PP, BSI Ventrassist 19
19 Viridans streptococci DL, SW, PP HM II 235
Gram-Negative
20 Pseudomonas
aeruginosa
DL, PP, BSI, VAD
pump housing
outflow
HM I 16
21 DL, SW, PP HM II 36
22 DL, BSI HM II 174
23 P. aeruginosa +/−
Pflourescens
DL HM I 130
24 P. aeruginosa and
Enterobacter
aerogenes
DL, PP HM I 206
25 Stenotrophomonas
maltophilia
DL HM II 237
26 Escherichia coli PP HM II 10
27 Enterobacter cloacae DL HM II 251
28 Proteus mirabilis DL HM II 242
29 Klebsiella
pneumoniae and
Morganella morganii
SW, PP, BSI HM I 36
30 Enterobacter,
K. pneumoniae
CoNS
DL HM II 168
31 Yeast
(Candida glabrata)
DL, PP, BSI,
eroded graft
–->exsanguination
HM I 60
32 Culture Negative DL, PP HM I 86
33 PP HM II 82
34 PP, outflow graft,
inner device
surface
HM II 65
*

DL, driveline; PP, pump pocket; SW, sternal wound; BSI, bloodstream infection.

HM I, Heartmate I®; HM II, Heartmate II®

Coagulase-negative staphylococcus (CoNS)